We are live on
!
Find out more
SACTSONJ
Supplemental Annuity Collective Trust (SACT) of New Jersey Portfolio holdings
AUM
$389M
1-Year Est. Return
49.94%
This Fund
S&P 500
This Quarter
Est. Return
+0.27%
1 Year Est. Return
+49.94%
3 Year Est. Return
+146.52%
5 Year Est. Return
+195.75%
10 Year Est. Return
+635.23%
AUM
$304M
AUM Growth
-$4.03M
(-1.3%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-0.8%
Top 10 Holdings %
Top 10 Hldgs %
33.12%
Holding
226
New
4
Increased
1
Reduced
6
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$618K |
| 2 |
GXO Logistics
GXO
|
+$314K |
| 3 |
Gartner
IT
|
+$203K |
| 4 |
Devon Energy
DVN
|
+$170K |
| 5 |
NSLR
Neostellar Capital Corp
NSLR
|
+$27.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$919K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$790K |
| 3 |
NAV
Navistar International
NAV
|
+$712K |
| 4 |
Amazon
AMZN
|
+$414K |
| 5 |
XPO
XPO
|
+$242K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Financials | 13.9% |
| 3 | Healthcare | 12.44% |
| 4 | Communication Services | 11.4% |
| 5 | Consumer Discretionary | 10.17% |
Similar funds
AIM
PFPGI
PG
SI
TCM
HBWM
EC
RC
Supplemental Annuity Collective Trust (SACT) of New Jersey's Q3 2021 Portfolio in Review
As of Q3 2021, Supplemental Annuity Collective Trust (SACT) of New Jersey held 226 positions worth $304M, down 1.3% from $308M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 3.1%. Supplemental Annuity Collective Trust (SACT) of New Jersey opened 4 new positions and exited 3, leaving the 226-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's largest Q3 2021 buy was AstraZeneca: 5,311 shares worth $638K.
- Supplemental Annuity Collective Trust (SACT) of New Jersey added most to Neostellar Capital Corp in Q3 2021, an estimated $27.7K increase.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's biggest Q3 2021 reduction was Bristol-Myers Squibb, cutting an estimated $790K.
- Supplemental Annuity Collective Trust (SACT) of New Jersey fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $919K.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's ten largest holdings make up 33% of its $304M portfolio in Q3 2021.
- Supplemental Annuity Collective Trust (SACT) of New Jersey opened 4 new positions and closed 3 in Q3 2021.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio value fell 1.3% quarter-over-quarter to $304M.
Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q3 2021, filed 26 Oct 2021.